Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives
Open Access
- 12 December 2023
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (12) , 2765
Abstract
Rational drug use in special populations is a clinical problem that doctors and pharma-cists must consider seriously. Neonates are the most physiologically immature and vulnerable to drug dosing. There is a pronounced difference in the anatomical and physiological profiles be-tween neonates and older people, affecting the absorption, distribution, metabolism, and excretion of drugs in vivo, ultimately leading to changes in drug concentration. Thus, dose adjustments in neonates are necessary to achieve adequate therapeutic concentrations and avoid drug toxicity. Over the past few decades, modeling and simulation techniques, especially physiologically based pharmacokinetic (PBPK) modeling, have been increasingly used in pediatric drug development and clinical therapy. This rigorously designed and verified model can effectively compensate for the deficiencies of clinical trials in neonates, provide a valuable reference for clinical research design, and even replace some clinical trials to predict drug plasma concentrations in newborns. This review introduces previous findings regarding age-dependent physiological changes and pathological factors affecting neonatal pharmacokinetics, along with their research means. The application of PBPK modeling in neonatal pharmacokinetic studies of various medications is also reviewed. Based on this, we propose future perspectives on neonatal PBPK modeling and hope for its broader application.Keywords
Funding Information
- National Natural Science Foundation Incubation Program of the Second Affiliated Hospital of Anhui Medical University (2022GQFY15, 82204527, 2022zhyx-B10)
- National Natural Science Foundation of China (2022GQFY15, 82204527, 2022zhyx-B10)
- Research Fund of the Anhui Institute of Translational Medicine (2022GQFY15, 82204527, 2022zhyx-B10)
This publication has 258 references indexed in Scilit:
- Application of Physiologically Based Pharmacokinetic Modeling to Predict Acetaminophen Metabolism and Pharmacokinetics in ChildrenCPT: Pharmacometrics & Systems Pharmacology, 2013
- Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trialCritical Care, 2012
- Interindividual Variability in Hepatic Expression of the Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2): Quantification by Liquid Chromatography/Tandem Mass SpectrometryDrug Metabolism and Disposition, 2012
- Prenatal and Postnatal Expression of Glutathione Transferase ζ 1 in Human Liver and the Roles of Haplotype and Subject Age in Determining Activity with DichloroacetateDrug Metabolism and Disposition, 2012
- Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal InfectionsThe Pediatric Infectious Disease Journal, 2011
- Higher clearance of micafungin in neonates compared with adults: role of age‐dependent micafungin serum bindingBiopharmaceutics & Drug Disposition, 2011
- What is the right dose for children?British Journal of Clinical Pharmacology, 2010
- Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and RegulationPharmacological Reviews, 2010
- In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and Flavin-Containing Monooxygenase 3Drug Metabolism and Disposition, 2010
- Human carboxylesterases HCE1 and HCE2: Ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrinBiochemical Pharmacology, 2009